These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 16672124)

  • 21. Artificial neural networks: has the time come for their use in prostate cancer patients?
    Stephan C; Cammann H; Jung K
    Nat Clin Pract Urol; 2005 Jun; 2(6):262-3. PubMed ID: 16474814
    [No Abstract]   [Full Text] [Related]  

  • 22. Predictive models in diagnosing indolent cancer.
    Bangma CH; Roobol MJ; Steyerberg EW
    Cancer; 2009 Jul; 115(13 Suppl):3100-6. PubMed ID: 19544551
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Neuro-fuzzy system for prostate cancer diagnosis.
    Benecchi L
    Urology; 2006 Aug; 68(2):357-61. PubMed ID: 16904452
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The use of nomograms in the detection of prostate cancer.
    Roobol MJ
    Prostate; 2006 Sep; 66(12):1266-7. PubMed ID: 16752374
    [No Abstract]   [Full Text] [Related]  

  • 25. Critical assessment of tools to predict clinically insignificant prostate cancer at radical prostatectomy in contemporary men.
    Chun FK; Haese A; Ahyai SA; Walz J; Suardi N; Capitanio U; Graefen M; Erbersdobler A; Huland H; Karakiewicz PI
    Cancer; 2008 Aug; 113(4):701-9. PubMed ID: 18553365
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Predicting outcomes in prostate cancer: how many more nomograms do we need?
    Ross RW; Kantoff PW
    J Clin Oncol; 2007 Aug; 25(24):3563-4. PubMed ID: 17704399
    [No Abstract]   [Full Text] [Related]  

  • 27. [Nomogram as predictive model in clinical practice].
    Ohori Tatsuo Gondo And Riu Hamada M; Gondo T; Hamada R
    Gan To Kagaku Ryoho; 2009 Jun; 36(6):901-6. PubMed ID: 19542708
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prediction tools in surgical oncology.
    Isariyawongse BK; Kattan MW
    Surg Oncol Clin N Am; 2012 Jul; 21(3):439-47, viii-ix. PubMed ID: 22583992
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A graphical device to represent the outcomes of a logistic regression analysis.
    Kranse R; Roobol M; Schröder FH
    Prostate; 2008 Nov; 68(15):1674-80. PubMed ID: 18712715
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Application of neural networks in occupational medicine].
    Mocci F
    G Ital Med Lav Ergon; 1998; 20(3):123-7. PubMed ID: 9788050
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Artificial neural network: is it free of problems?
    Akten AO; Ankara MT
    BJU Int; 2008 Sep; 102(7):902; author reply 902. PubMed ID: 18821923
    [No Abstract]   [Full Text] [Related]  

  • 32. A nomogram for predicting low-volume/low-grade prostate cancer: a tool in selecting patients for active surveillance.
    Nakanishi H; Wang X; Ochiai A; Trpkov K; Yilmaz A; Donnelly JB; Davis JW; Troncoso P; Babaian RJ
    Cancer; 2007 Dec; 110(11):2441-7. PubMed ID: 17932909
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Editorial comment on: Is prostate-specific antigen velocity selective for clinically significant prostate cancer in screening? European Randomized Study of Screening for Prostate Cancer (Rotterdam).
    Terris MK
    Eur Urol; 2009 Feb; 55(2):392; discussion 393. PubMed ID: 18353530
    [No Abstract]   [Full Text] [Related]  

  • 34. An introduction to artificial neural networks in bioinformatics--application to complex microarray and mass spectrometry datasets in cancer studies.
    Lancashire LJ; Lemetre C; Ball GR
    Brief Bioinform; 2009 May; 10(3):315-29. PubMed ID: 19307287
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Information content of five nomograms for outcomes in prostate cancer.
    Bismar TA; Humphrey P; Vollmer RT
    Am J Clin Pathol; 2007 Nov; 128(5):803-7. PubMed ID: 17951203
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Current validity of nomograms for prostate cancer staging].
    Fernando AB; Sanz G; Esteban LM; Sanz MJ; Martínez PG; de Jalón AG; Frago PS; Losa CA; Sanz LA
    Arch Esp Urol; 2006 Dec; 59(10):989-1000. PubMed ID: 17283712
    [TBL] [Abstract][Full Text] [Related]  

  • 37. An updated catalog of prostate cancer predictive tools.
    Shariat SF; Karakiewicz PI; Roehrborn CG; Kattan MW
    Cancer; 2008 Dec; 113(11):3075-99. PubMed ID: 18823041
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Predictive models of toxicity with external radiotherapy for prostate cancer: clinical issues.
    Valdagni R; Rancati T; Fiorino C
    Cancer; 2009 Jul; 115(13 Suppl):3141-9. PubMed ID: 19544543
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Development of a nomogram for predicting high-grade prostate cancer on biopsy: the significance of serum testosterone levels.
    Ide H; Yasuda M; Nishio K; Saito K; Isotani S; Kamiyama Y; Muto S; Horie S
    Anticancer Res; 2008; 28(4C):2487-92. PubMed ID: 18751439
    [TBL] [Abstract][Full Text] [Related]  

  • 40. PSA and new biomarkers within multivariate models to improve early detection of prostate cancer.
    Stephan C; Cammann H; Meyer HA; Lein M; Jung K
    Cancer Lett; 2007 Apr; 249(1):18-29. PubMed ID: 17292541
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.